Experimental and clinical approaches to a radioimmunotherapy in o
Molecular nuclear medicine plays an important role in the diagnosis and therapy of cancer. Radioimmunodetection and radioimmunotherapy (RIT) involve the use of antibodies conjugated with diagnostic or therapeutic radionuclides, respectively. More often for RIT use the monoclonal antibodies against t...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-02-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/53 |
| _version_ | 1797875939401531392 |
|---|---|
| author | E. V. Abakushina D. N. Abakushin Ju. N. Anohin |
| author_facet | E. V. Abakushina D. N. Abakushin Ju. N. Anohin |
| author_sort | E. V. Abakushina |
| collection | DOAJ |
| description | Molecular nuclear medicine plays an important role in the diagnosis and therapy of cancer. Radioimmunodetection and radioimmunotherapy (RIT) involve the use of antibodies conjugated with diagnostic or therapeutic radionuclides, respectively. More often for RIT use the monoclonal antibodies against tumor-associated antigens, radiolabeled with alpha or beta-emitters. Encouraging results have been achieved with this technology in the management of hematologic malignancies. On the contrary, solid tumors have been less responsive. Radioimmunotherapy therefore is considered more suitable for the treatment of microscopic or minimal residual disease, allowing radiolabeled monoclonal antibodies to achieve uptake in tumors high enough to result in tumoricidal radiation doses. Despite these encouraging results, new potential target for radioimmunodetection and RIT should be found. For this purpose, a series of experiments will be performing to investigate the biodistribution and the therapeutic efficacy of radiolabeled monoclonal antibodies in cell culture and animal models. |
| first_indexed | 2024-04-10T01:55:26Z |
| format | Article |
| id | doaj.art-84820e303e144f3884a8f9f3bd284e74 |
| institution | Directory Open Access Journal |
| issn | 1814-4861 2312-3168 |
| language | Russian |
| last_indexed | 2024-04-10T01:55:26Z |
| publishDate | 2016-02-01 |
| publisher | Russian Academy of Sciences, Tomsk National Research Medical Center |
| record_format | Article |
| series | Сибирский онкологический журнал |
| spelling | doaj.art-84820e303e144f3884a8f9f3bd284e742023-03-13T09:05:46ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682016-02-0103566453Experimental and clinical approaches to a radioimmunotherapy in oE. V. Abakushina0D. N. Abakushin1Ju. N. Anohin2ФГБУ «Медицинский радиологический научный центр» Минздрава России, г. Обнинск Обнинский институт атомной энергетики – филиал ФГАОУ ВПО «Национальный исследовательский ядерный университет» «МИФИ», г. ОбнинскООО «Клиника № 1», г. ОбнинскОбнинский институт атомной энергетики – филиал ФГАОУ ВПО «Национальный исследовательский ядерный университет» «МИФИ», г. ОбнинскMolecular nuclear medicine plays an important role in the diagnosis and therapy of cancer. Radioimmunodetection and radioimmunotherapy (RIT) involve the use of antibodies conjugated with diagnostic or therapeutic radionuclides, respectively. More often for RIT use the monoclonal antibodies against tumor-associated antigens, radiolabeled with alpha or beta-emitters. Encouraging results have been achieved with this technology in the management of hematologic malignancies. On the contrary, solid tumors have been less responsive. Radioimmunotherapy therefore is considered more suitable for the treatment of microscopic or minimal residual disease, allowing radiolabeled monoclonal antibodies to achieve uptake in tumors high enough to result in tumoricidal radiation doses. Despite these encouraging results, new potential target for radioimmunodetection and RIT should be found. For this purpose, a series of experiments will be performing to investigate the biodistribution and the therapeutic efficacy of radiolabeled monoclonal antibodies in cell culture and animal models.https://www.siboncoj.ru/jour/article/view/53радиоиммунотерапиязлокачественные новообразованиямоноклональные антителаопухолеассоциированные антигенырадиоизотоп |
| spellingShingle | E. V. Abakushina D. N. Abakushin Ju. N. Anohin Experimental and clinical approaches to a radioimmunotherapy in o Сибирский онкологический журнал радиоиммунотерапия злокачественные новообразования моноклональные антитела опухолеассоциированные антигены радиоизотоп |
| title | Experimental and clinical approaches to a radioimmunotherapy in o |
| title_full | Experimental and clinical approaches to a radioimmunotherapy in o |
| title_fullStr | Experimental and clinical approaches to a radioimmunotherapy in o |
| title_full_unstemmed | Experimental and clinical approaches to a radioimmunotherapy in o |
| title_short | Experimental and clinical approaches to a radioimmunotherapy in o |
| title_sort | experimental and clinical approaches to a radioimmunotherapy in o |
| topic | радиоиммунотерапия злокачественные новообразования моноклональные антитела опухолеассоциированные антигены радиоизотоп |
| url | https://www.siboncoj.ru/jour/article/view/53 |
| work_keys_str_mv | AT evabakushina experimentalandclinicalapproachestoaradioimmunotherapyino AT dnabakushin experimentalandclinicalapproachestoaradioimmunotherapyino AT junanohin experimentalandclinicalapproachestoaradioimmunotherapyino |